Metformin inhibits the over-expression of classical EMT markers such as SNAIL and zinc finger E-box binding homeobox (ZEB) by potentiating the expression of miR-34a and miR-200 to prevent colorectal cancer progression and/or tumor recurrence [61]. This evidence concerns the gene SNAI1 and neoplasm.